1. Long term biventricular support with Berlin Heart Excor in a Septuagenarian with giant-cell myocarditis.
- Author
-
Bireta C, Tirilomis T, Grossmann M, Unsöld B, Wachter R, Perl T, Jebran AF, Schoendube FA, and Popov AF
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Cyclosporine therapeutic use, Extracorporeal Membrane Oxygenation, Follow-Up Studies, Heart Failure etiology, Humans, Immunosuppressive Agents therapeutic use, Male, Prednisolone therapeutic use, Prosthesis-Related Infections drug therapy, Pseudomonas Infections drug therapy, Shock, Cardiogenic etiology, Staphylococcal Infections drug therapy, Treatment Outcome, Heart Failure surgery, Heart-Assist Devices, Myocarditis complications
- Abstract
Giant-cell myocarditis (GCM) is known as a rare, rapidly progressive, and frequently fatal myocardial disease in young and middle-aged adults. We report about a 76 year old male patient who underwent implantation with a biventricular Berlin Heart Excor system at the age of 74 due to acute biventricular heart failure caused by giant-cell myocarditis. The implantation was without any surgical problems; however, a difficulty was the immunosuppressive therapy after implantation. Meanwhile the patient is 76 years old and lives with circulatory support for about 3 years without major adverse events. Also, in terms of mobility in old age there are no major limitations. It seems that in even selected elderly patients an implantation of a long term support with the biventricular Berlin Heart Excor is a useful therapeutic option with an acceptable outcome.
- Published
- 2015
- Full Text
- View/download PDF